Mallinckrodt research fellowship award program announcement

Mallinckrodt research fellowship award program announcement

Mallinckrodt Research Fellowship Award Program Announcement

Mallinckrodt Pharmaceuticals is pleased to announce the Research Fellowship Award Program granting a total of 25 positions funded in neurology, nephrology, rheumatology, pulmonology, severe spasticity of CNS origin, acute pain, as well as the management of pain. The program will provide grants to fellows, junior clinicians, residents and post-doctoral researchers pursuing a research-oriented career in the area of clinical, translational, or basic research to be conducted at eligible institutions and fulfills an unmet medical need or addresses essential scientific questions.

We invite you to submit a fellowship application by visiting www.mallinckrodt.com/Fellowships prior to the application deadline of May 30, 2015. The award amount is $80,000/year for 2 years with the second year contingent on the research progress made in the first year. Thank you for your interest.

CMSC Disclaimer

The industry news information and articles are for informational purposes only, and are not intended to represent any trends, partnerships, commitments, or research of the Consortium of MS Centers or any of it's members in any way whatsoever, nor should any party be libel in any way to the reader or to any other person, firm or corporation reading this industry news section. Although the CMSC site includes links providing direct access to other Internet sites, CMSC takes no responsibility for the content or information contained on those other sites, and does not exert any editorial or other control over those other sites. CMSC is providing information and services on the Internet as a benefit and service in furtherance of CMSC's nonprofit and tax-exempt status. CMSC makes no representations about the suitability of this information and these services for any purpose.

Elizabeth Porco

Comments are closed.

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last